A report by Vivek Singla of The Economic Times compared the Indian private equity industry to a valiant warrior who is able to penetrate an enemy's circle of defense, but failed because he had no exit plan.
The Economic Times
Breaking News
US-based generic drug manufacturer Mylan and two Indian pharmaceutical firms are in talks to buy Chennai-based Bafna Pharmaceuticals for an undisclosed amount, according to two sources familiar with the transaction.
With almost 150 plot bookings from MSME companies, Gujarat's plastic park at Dahej and Sanand are expected to attract around INR5000 crore worth of investment in India.
Two private equity firms, Axon Capital and Forum Synergies, together bought a minority stake in Bangalore-based online food ordering portal Justeat.in for an undisclosed amount.
Subscribe to VCpost newsletter
Most Popular
- Former CEO Shoots Himself to Commit Suicide After Receiving $25 Million Record-Breaking Fine for Fraud at Steinhoff
- Xi Jinping Warns Dutch PM That 'No Force' Can Stop China's Technological Advancement Amid Export Restrictions
- Taylor Swift Reaches Her Billionaire' Era,' Joining Elon Musk and Jeff Bezos on the List of World's Wealthiest People
- Businessman Brutally Murdered Allegedly by 4 of His Workers Who Swung an Axe Into His Head
- Social Security Benefits to Increase for Some Seniors After Addressing Overpayment Issues
- Major AI Companies Unite to Create the World's First Artificial Superintelligence Alliance Worth $7.6 Billion
- Disney Investor Nelson Peltz Criticizes the Company’s 'Woke' Strategy, Questioning 'Black Panther' and 'The Marvels' Films
- Four Deaths May Be Linked to Dietary Supplements Made by Japan’s Kobayashi Pharmaceutical: Report